136 related articles for article (PubMed ID: 37522559)
1. The Potential Role of Cytotoxic Immune Effectors in Amyotrophic Lateral Sclerosis (ALS); A Longitudinal Case Study Comparing Patients with Genetically Identical Healthy Twin.
Kaur K; Chen PC; Ko MW; Huerta-Yepez S; Maharaj D; Jewett A
Crit Rev Immunol; 2023; 43(1):27-39. PubMed ID: 37522559
[TBL] [Abstract][Full Text] [Related]
2. The Potential Role of Cytotoxic Immune Effectors in Induction, Progression and Pathogenesis of Amyotrophic Lateral Sclerosis (ALS).
Kaur K; Chen PC; Ko MW; Mei A; Chovatiya N; Huerta-Yepez S; Ni W; Mackay S; Zhou J; Maharaj D; Malarkannan S; Jewett A
Cells; 2022 Oct; 11(21):. PubMed ID: 36359827
[TBL] [Abstract][Full Text] [Related]
3. Successes and Challenges in Taming the Beast: Cytotoxic Immune Effectors in Amyotrophic Lateral Sclerosis.
Kaur K; Chen PC; Ko MW; Mei A; Huerta-Yepez S; Maharaj D; Malarkannan S; Jewett A
Crit Rev Immunol; 2023; 43(1):1-11. PubMed ID: 37522557
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Cytotoxic Immune Effector Function by AJ3 Probiotic Bacteria in Amyotrophic Lateral Sclerosis (ALS).
Chen PC; Kaur K; Ko MW; Huerta-Yepez S; Jain Y; Jewett A
Crit Rev Immunol; 2023; 43(1):13-26. PubMed ID: 37522558
[TBL] [Abstract][Full Text] [Related]
5. Role of the immune system in amyotrophic lateral sclerosis. Analysis of the natural killer cells and other circulating lymphocytes in a cohort of ALS patients.
Piccoli T; Castro F; La Bella V; Meraviglia S; Di Simone M; Salemi G; Dieli F; Spataro R
BMC Neurol; 2023 Jun; 23(1):222. PubMed ID: 37296379
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic CD8
Coque E; Salsac C; Espinosa-Carrasco G; Varga B; Degauque N; Cadoux M; Crabé R; Virenque A; Soulard C; Fierle JK; Brodovitch A; Libralato M; Végh AG; Venteo S; Scamps F; Boucraut J; Laplaud D; Hernandez J; Gergely C; Vincent T; Raoul C
Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2312-2317. PubMed ID: 30674678
[TBL] [Abstract][Full Text] [Related]
7. Tofacitinib Suppresses Natural Killer Cells
Figueroa-Romero C; Monteagudo A; Murdock BJ; Famie JP; Webber-Davis IF; Piecuch CE; Teener SJ; Pacut C; Goutman SA; Feldman EL
Front Immunol; 2022; 13():773288. PubMed ID: 35197969
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulatory Properties of Bone Marrow Mesenchymal Stem Cells from Patients with Amyotrophic Lateral Sclerosis and Healthy Donors.
Javorkova E; Matejckova N; Zajicova A; Hermankova B; Hajkova M; Bohacova P; Kossl J; Krulova M; Holan V
J Neuroimmune Pharmacol; 2019 Jun; 14(2):215-225. PubMed ID: 30242613
[TBL] [Abstract][Full Text] [Related]
9. Low T-cell reactivity to TDP-43 peptides in ALS.
Ramachandran S; Grozdanov V; Leins B; Kandler K; Witzel S; Mulaw M; Ludolph AC; Weishaupt JH; Danzer KM
Front Immunol; 2023; 14():1193507. PubMed ID: 37545536
[TBL] [Abstract][Full Text] [Related]
10. Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis: A Study of Humans and a Transgenic Mouse Model.
Sheean RK; McKay FC; Cretney E; Bye CR; Perera ND; Tomas D; Weston RA; Scheller KJ; Djouma E; Menon P; Schibeci SD; Marmash N; Yerbury JJ; Nutt SL; Booth DR; Stewart GJ; Kiernan MC; Vucic S; Turner BJ
JAMA Neurol; 2018 Jun; 75(6):681-689. PubMed ID: 29507931
[TBL] [Abstract][Full Text] [Related]
11. Low Memory T Cells Blood Counts and High Naïve Regulatory T Cells Percentage at Relapsing Remitting Multiple Sclerosis Diagnosis.
Canto-Gomes J; Silva CS; Rb-Silva R; Boleixa D; da Silva AM; Cheynier R; Costa P; González-Suárez I; Correia-Neves M; Cerqueira JJ; Nobrega C
Front Immunol; 2022; 13():901165. PubMed ID: 35711452
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells-related immune traits and amyotrophic lateral sclerosis: A Mendelian randomization study.
Gong Z; Liu Y; Ding F; Ba L; Zhang M
Front Neurosci; 2022; 16():981371. PubMed ID: 36248644
[TBL] [Abstract][Full Text] [Related]
13. Alterations of T cell subsets in ALS: a systemic immune activation?
Rentzos M; Evangelopoulos E; Sereti E; Zouvelou V; Marmara S; Alexakis T; Evdokimidis I
Acta Neurol Scand; 2012 Apr; 125(4):260-4. PubMed ID: 21651502
[TBL] [Abstract][Full Text] [Related]
14. Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation.
Rolfes L; Schulte-Mecklenbeck A; Schreiber S; Vielhaber S; Herty M; Marten A; Pfeuffer S; Ruck T; Wiendl H; Gross CC; Meuth SG; Boentert M; Pawlitzki M
Brain Commun; 2021; 3(3):fcab157. PubMed ID: 34405141
[TBL] [Abstract][Full Text] [Related]
15. N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model.
Li W; Fotinos A; Wu Q; Chen Y; Zhu Y; Baranov S; Tu Y; Zhou EW; Sinha B; Kristal BS; Wang X
Neurobiol Dis; 2015 Aug; 80():93-103. PubMed ID: 25986728
[TBL] [Abstract][Full Text] [Related]
16. Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis.
Jin M; Günther R; Akgün K; Hermann A; Ziemssen T
Sci Rep; 2020 Apr; 10(1):5941. PubMed ID: 32246039
[TBL] [Abstract][Full Text] [Related]
17. Correlation between leukocyte phenotypes and prognosis of amyotrophic lateral sclerosis.
Cui C; Ingre C; Yin L; Li X; Andersson J; Seitz C; Ruffin N; Pawitan Y; Piehl F; Fang F
Elife; 2022 Mar; 11():. PubMed ID: 35287794
[TBL] [Abstract][Full Text] [Related]
18. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients.
Lam L; Chin L; Halder RC; Sagong B; Famenini S; Sayre J; Montoya D; Rubbi L; Pellegrini M; Fiala M
FASEB J; 2016 Oct; 30(10):3461-3473. PubMed ID: 27368295
[TBL] [Abstract][Full Text] [Related]
20. Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression.
Murdock BJ; Zhou T; Kashlan SR; Little RJ; Goutman SA; Feldman EL
JAMA Neurol; 2017 Dec; 74(12):1446-1454. PubMed ID: 28973548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
